Clinical Trials Logo

Hepatitis B clinical trials

View clinical trials related to Hepatitis B.

Filter by:
  • Approved for marketing  
  • Page 1

NCT ID: NCT01198860 Approved for marketing - CHRONIC HEPATITIS B Clinical Trials

Treatment on HBeAg Positive or HBeAg Negative in Chronic Hepatitis B

HBV
Start date: n/a
Phase:
Study type: Expanded Access

Phyllanthus Urinaria - Adenosma Glutinosum - Eclipta Prostrata - Ascorbic Acid combination plus Tenofovir in treatment of acute and chronic hepatitis B. Method the combination of drugs derived from natural and artificial medicaments. Has stronger effect on immune system, effective good against HBV replication. This is a substantial new insight into the pathogenesis of disease, with a clear path toward clinical application, or which would lead to a substantial advance and perfect in management or public health policy.

NCT ID: NCT00042393 Approved for marketing - Chronic Hepatitis B Clinical Trials

An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options

Start date: n/a
Phase: Phase 3
Study type: Expanded Access

The purpose of this early access protocol is to provide access to adefovir dipivoxil prior to its commercial availability to people with lamivudine-resistant chronic hepatitis B who have limited treatment options.